Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF + MTX vs CYC/AZA in Active Takayasu's Arteritis
NCT03096275Phase 3Completed
- Sponsor
- Chinese SLE Treatment And Research Group
- Start
- Mar 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in Takayasu's arteritis (TAK), sponsored by Chinese SLE Treatment And Research Group. Started Mar 2017; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Takayasu's arteritis (TAK)
Beyond the preview
Go deeper on NCT03096275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096275.